SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001126234-20-000076
Filing Date
2020-06-02
Accepted
2020-06-02 17:21:39
Documents
52
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nlnk-20200331.htm   iXBRL 10-Q 1388862
2 EX-31.1 nlnk-2020331x10qxex311.htm EX-31.1 11570
3 EX-31.2 nlnk-2020331x10qxex312.htm EX-31.2 12041
4 EX-32.1 nlnk-2020331x10qxex321.htm EX-32.1 8880
10 nlnk-20200331_g1.jpg GRAPHIC 12762
11 nlnk-20200331_g2.jpg GRAPHIC 191784
  Complete submission text file 0001126234-20-000076.txt   4959624

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20200331.xsd EX-101.SCH 26534
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20200331_cal.xml EX-101.CAL 61423
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20200331_def.xml EX-101.DEF 164201
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20200331_lab.xml EX-101.LAB 380169
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20200331_pre.xml EX-101.PRE 244665
22 EXTRACTED XBRL INSTANCE DOCUMENT nlnk-20200331_htm.xml XML 521675
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35342 | Film No.: 20938143
SIC: 2834 Pharmaceutical Preparations